@2025 Afarand., IRAN
ISSN: 2252-0805 The Horizon of Medical Sciences 2018;24(2):139-145
ISSN: 2252-0805 The Horizon of Medical Sciences 2018;24(2):139-145
Comparison of Effectiveness of Dynamic-Supportive Psychotherapy and Pharmacotherapy on Type 2 Diabetes Patients’ Depression
ARTICLE INFO
Article Type
Original ResearchAuthors
Nayyeri M (1)Rajaee A (*)
Meschi F (2)
Sodagar S (3)
(*) Psychology Department, Torbat -e - Jam Branch, Islamic Azad University, Torbat -e - Jam, Iran
(1) Health Psychology Department, Karaj Branch, Islamic Azad University, Karaj, Iran
(2) Health Psychology Department, Karaj Branch, Islamic Azad University, Karaj, Iran
(3) Health Psychology Department, Karaj Branch, Islamic Azad University, Karaj, Iran
Correspondence
Address: Psychology Department, torbat -e - jam Branch, Islamic Azad University, torbat -e - jam, 5 km to Torbat-e-Jam, Torbat-e-Jam to Mashhad Road, Khorasan Razavi, Iran. Postal Code: 9576174814Phone: +98 (51) 52510222
Fax: +98 (51) 52510080
rajaei.46@yahoo.com
Article History
Received: September 17, 2017Accepted: May 2, 2018
ePublished: May 16, 2018
ABSTRACT
Aims
Type 2 diabetes is one of the major causes of death. Depression disorder
is one of the most common unresponsive problems in these patients which can
affect the disease prognosis. The aim of this study is comparison of effectiveness
of dynamic-supportive psychotherapy and pharmacotherapy on type 2 diabetes
patients’ depression.
Materials & Methods This semi experimental study was conducted with pre-test and post-test design with control group in 2016. In this research there were 30 sample diagnosed with moderate to severe depression selected by randomized sampling in two experimental groups and one control group. The Dynamic-Supportive group is scheduled to undergo 10 sessions of psychotherapy and the drug treatment group that received under the supervision of the psychiatrist will take the prescribed medications. The collected data were analyzed by the covariance test.
Findings The results showed that each of the dynamic-supportive treatments and pharmacotherapy had a significant difference comparing to the control group (p< 0.001), which was effective in depression treatment, but there was no significant difference between two treatment methods of dynamic-supportive and pharmacotherapy.
Conclusion In type 2 diabetic patients who have to use drug to control their illness, dynamic-supportive treatment can be an appropriate alternative to decrease depression instead of pharmacotherapy.
Materials & Methods This semi experimental study was conducted with pre-test and post-test design with control group in 2016. In this research there were 30 sample diagnosed with moderate to severe depression selected by randomized sampling in two experimental groups and one control group. The Dynamic-Supportive group is scheduled to undergo 10 sessions of psychotherapy and the drug treatment group that received under the supervision of the psychiatrist will take the prescribed medications. The collected data were analyzed by the covariance test.
Findings The results showed that each of the dynamic-supportive treatments and pharmacotherapy had a significant difference comparing to the control group (p< 0.001), which was effective in depression treatment, but there was no significant difference between two treatment methods of dynamic-supportive and pharmacotherapy.
Conclusion In type 2 diabetic patients who have to use drug to control their illness, dynamic-supportive treatment can be an appropriate alternative to decrease depression instead of pharmacotherapy.
CITATION LINKS
[1]Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311-21.
[2]King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414-31.
[3]Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53.
[4]Diabetes Research Center. Diabetes and depression. Endocrinology and Metabolism Research Institute of Medical Sciences. Tehran: Vis Pre; 2011. [Persian]
[5]Kessing LV, Nilsson FM, Siersma V, Andersen PK. No increased risk of developing depression in diabetes compared to other chronic illness. Diabetes Res Clin Pract. 2003;62(2):113-21.
[6]Afshar M, Isaac Hosseini M. What is diabetes?. 6th.Ed. Kashan: Morsal; 2008. [Persian]
[7]Turner J, Kelly B. Emotional dimensions of chronic disease. West J Med. 2000;172(2):124-8.
[8]Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24(6):1069-78.
[9]Steele TE, Finkelstein SH, Finkelstein FO. Marital discord, sexual problems, and depression. J Nerv Ment Dis. 1976;162(4):225-37.
[10]Katon WJ. The comorbidity of diabetes mellitus and depression. Am J Med. 2008;121(11 Suppl 2):S8-15.
[11]Li C, Ford ES, Zhao G, Ahluwalia IB, Pearson WS, Mokdad AH. Prevalence and correlates of undiagnosed depression among U.S. adults with diabetes: the behavioral risk factor surveillance system, 2006. Diabetes Res Clin Pract. 2009;83(2):268-79.
[12]Sarshar N, Chamanzari H. Diabetes complications in patients referred to Gonabad Diabetes Clinic. Horiz Med Sci. 2003;9(1):62-9. [Persian]
[13]Unknown author. Epidemiology of Diabetes. Diabetes and depression, atrocious cycle. 2001;21(9).
[14]Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000;23(7):934-42.
[15]Allen F, Fisher M, Phipps N. The correlation between depression and diabetes. US Pharma. 2014;39(10):12-15.
[16]Winston A, Rosenthal RN, Pinsker H. Learning supportive psychotherapy: an illustrated guide. Arlington: American Psychiatric Pub; 2012.
[17]Crown S. Supportive psychotherapy: a contradiction in terms. Br J Psychiatry. 1988;152:855-7.
[18]Markowitz SM, Gonzalez JS, Wilkinson JL, Safren SA. A review of treating depression in diabetes: emerging findings. Psychosomatics. 2011;52(1):1-18.
[19]Petrak F, Baumeister H, Skinner TC, Brown A, Holt RIG. Depression and diabetes: treatment and health-care delivery. Lancet Diabetes Endocrinol. 2015;3(6):472-85.
[20]Ucok K, Acay A, Coskun KS, Alpaslan AH, Coban NF, Akkan G, et al. Evaluation anxiety, depression, and health-related quality of life in male and female patients with newly diagnosed type 2 diabetes. Bullet Clin Psychoph. 2015;25(1):169-70.
[21]Kiadaliri AA, Najafi B, Mirmalek-Sani M. Quality of life in people with diabetes: a systematic review of studies in Iran. J Diabetes Metab Disord. 2013;12(1):54.
[22]Khodabakhshi Koolaee A, Navidian A, Baiati Z, Rahmatizadeh M. Effectiveness of supportive psychotherapy on quality of life in patients with type2 diabetes. J Diabetes Nurs. 2015;3(3):31-41. [Persian]
[23]Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995;33(3):335-43.
[24]Sahebi A, Asghari MJ, Salari RS. Validation of Depression Anxiety and Stress Scale (DASS-21) for an Iranian Population. J Dev Psychol. 2005;1(4):36-54. [Persian]
[25]Misch DA. Basic strategies of dynamic supportive therapy. J Psychother Pract Res. 2000;9(4):173-89.
[2]King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414-31.
[3]Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53.
[4]Diabetes Research Center. Diabetes and depression. Endocrinology and Metabolism Research Institute of Medical Sciences. Tehran: Vis Pre; 2011. [Persian]
[5]Kessing LV, Nilsson FM, Siersma V, Andersen PK. No increased risk of developing depression in diabetes compared to other chronic illness. Diabetes Res Clin Pract. 2003;62(2):113-21.
[6]Afshar M, Isaac Hosseini M. What is diabetes?. 6th.Ed. Kashan: Morsal; 2008. [Persian]
[7]Turner J, Kelly B. Emotional dimensions of chronic disease. West J Med. 2000;172(2):124-8.
[8]Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24(6):1069-78.
[9]Steele TE, Finkelstein SH, Finkelstein FO. Marital discord, sexual problems, and depression. J Nerv Ment Dis. 1976;162(4):225-37.
[10]Katon WJ. The comorbidity of diabetes mellitus and depression. Am J Med. 2008;121(11 Suppl 2):S8-15.
[11]Li C, Ford ES, Zhao G, Ahluwalia IB, Pearson WS, Mokdad AH. Prevalence and correlates of undiagnosed depression among U.S. adults with diabetes: the behavioral risk factor surveillance system, 2006. Diabetes Res Clin Pract. 2009;83(2):268-79.
[12]Sarshar N, Chamanzari H. Diabetes complications in patients referred to Gonabad Diabetes Clinic. Horiz Med Sci. 2003;9(1):62-9. [Persian]
[13]Unknown author. Epidemiology of Diabetes. Diabetes and depression, atrocious cycle. 2001;21(9).
[14]Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000;23(7):934-42.
[15]Allen F, Fisher M, Phipps N. The correlation between depression and diabetes. US Pharma. 2014;39(10):12-15.
[16]Winston A, Rosenthal RN, Pinsker H. Learning supportive psychotherapy: an illustrated guide. Arlington: American Psychiatric Pub; 2012.
[17]Crown S. Supportive psychotherapy: a contradiction in terms. Br J Psychiatry. 1988;152:855-7.
[18]Markowitz SM, Gonzalez JS, Wilkinson JL, Safren SA. A review of treating depression in diabetes: emerging findings. Psychosomatics. 2011;52(1):1-18.
[19]Petrak F, Baumeister H, Skinner TC, Brown A, Holt RIG. Depression and diabetes: treatment and health-care delivery. Lancet Diabetes Endocrinol. 2015;3(6):472-85.
[20]Ucok K, Acay A, Coskun KS, Alpaslan AH, Coban NF, Akkan G, et al. Evaluation anxiety, depression, and health-related quality of life in male and female patients with newly diagnosed type 2 diabetes. Bullet Clin Psychoph. 2015;25(1):169-70.
[21]Kiadaliri AA, Najafi B, Mirmalek-Sani M. Quality of life in people with diabetes: a systematic review of studies in Iran. J Diabetes Metab Disord. 2013;12(1):54.
[22]Khodabakhshi Koolaee A, Navidian A, Baiati Z, Rahmatizadeh M. Effectiveness of supportive psychotherapy on quality of life in patients with type2 diabetes. J Diabetes Nurs. 2015;3(3):31-41. [Persian]
[23]Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995;33(3):335-43.
[24]Sahebi A, Asghari MJ, Salari RS. Validation of Depression Anxiety and Stress Scale (DASS-21) for an Iranian Population. J Dev Psychol. 2005;1(4):36-54. [Persian]
[25]Misch DA. Basic strategies of dynamic supportive therapy. J Psychother Pract Res. 2000;9(4):173-89.